Analyst Ratings for Novo Nordisk (NVO)
NVO Rating Summary
NVO Price Target Summary
- Highest: $70.00 (HSBC)
- Lowest: $40.00 (Morgan Stanley)
- Average: $48.13
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$48.13 (+11.7%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/11/2026 | Morgan Stanley | Thibault Boutherin | Downgrade | Underweight (Equalweight) |
40.00 (N/A) |
44.56 (43.07) |
-3.34% | Details |
| 8/12/2026 | Berenberg | Kerry Holford | Downgrade | Hold (Buy) |
47.00 (50.00) |
47.73 (43.07) |
-9.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
